A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of Linustedastat (OG-6219) in Women with Moderate to Severe Endometriosis-Related Pain.

Arbelaez F, Yureneva J, Larsson P, Colaci D, Gordon K, Dupclay L, Wilk K.

Open source

DOI
10.2147/ijwh.s622776
Published
2026-09-09
Container
Int J Womens Health
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ijwh.s622776,
  title = {A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of Linustedastat (OG-6219) in Women with Moderate to Severe Endometriosis-Related Pain.},
  author = {Arbelaez F and  Yureneva J and  Larsson P and  Colaci D and  Gordon K and  Dupclay L and  Wilk K.},
  year = {2026},
  journal = {Int J Womens Health},
  doi = {10.2147/ijwh.s622776},
  url = {https://doi.org/10.2147/ijwh.s622776}
}

RIS

TY  - JOUR
TI  - A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of Linustedastat (OG-6219) in Women with Moderate to Severe Endometriosis-Related Pain.
AU  - Arbelaez F
AU  -  Yureneva J
AU  -  Larsson P
AU  -  Colaci D
AU  -  Gordon K
AU  -  Dupclay L
AU  -  Wilk K.
PY  - 2026
JO  - Int J Womens Health
DO  - 10.2147/ijwh.s622776
UR  - https://doi.org/10.2147/ijwh.s622776
ER  - 

APA

F, A., J, Y., P, L., D, C., K, G., L, D., & K., W. (2026). A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of Linustedastat (OG-6219) in Women with Moderate to Severe Endometriosis-Related Pain.. Int J Womens Health. https://doi.org/10.2147/ijwh.s622776

Source records